Ad is loading...
QLGN
Price
$3.60
Change
-$0.46 (-11.33%)
Updated
Nov 15 closing price
VERU
Price
$0.58
Change
-$0.05 (-7.94%)
Updated
Nov 15 closing price
15 days until earnings call
Ad is loading...

QLGN vs VERU

Header iconQLGN vs VERU Comparison
Open Charts QLGN vs VERUBanner chart's image
Qualigen Therapeutics
Price$3.60
Change-$0.46 (-11.33%)
Volume$42.37K
CapitalizationN/A
Veru
Price$0.58
Change-$0.05 (-7.94%)
Volume$1.35M
CapitalizationN/A
QLGN vs VERU Comparison Chart
Loading...
QLGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VERU
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
QLGN vs. VERU commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QLGN is a Sell and VERU is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (QLGN: $3.60 vs. VERU: $0.58)
Brand notoriety: QLGN and VERU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: QLGN: 46% vs. VERU: 180%
Market capitalization -- QLGN: $2.65M vs. VERU: $85.43M
QLGN [@Biotechnology] is valued at $2.65M. VERU’s [@Biotechnology] market capitalization is $85.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QLGN’s FA Score shows that 1 FA rating(s) are green whileVERU’s FA Score has 0 green FA rating(s).

  • QLGN’s FA Score: 1 green, 4 red.
  • VERU’s FA Score: 0 green, 5 red.
According to our system of comparison, QLGN is a better buy in the long-term than VERU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QLGN’s TA Score shows that 4 TA indicator(s) are bullish while VERU’s TA Score has 3 bullish TA indicator(s).

  • QLGN’s TA Score: 4 bullish, 4 bearish.
  • VERU’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, QLGN is a better buy in the short-term than VERU.

Price Growth

QLGN (@Biotechnology) experienced а -24.53% price change this week, while VERU (@Biotechnology) price change was -20.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

QLGN is expected to report earnings on Mar 01, 2023.

VERU is expected to report earnings on Feb 05, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERU($85.4M) has a higher market cap than QLGN($2.65M). VERU YTD gains are higher at: -18.944 vs. QLGN (-86.909). QLGN has higher annual earnings (EBITDA): -8.22M vs. VERU (-35.59M). VERU has more cash in the bank: 29.2M vs. QLGN (119K). QLGN has less debt than VERU: QLGN (1.67M) vs VERU (13.7M). VERU has higher revenues than QLGN: VERU (14.1M) vs QLGN (0).
QLGNVERUQLGN / VERU
Capitalization2.65M85.4M3%
EBITDA-8.22M-35.59M23%
Gain YTD-86.909-18.944459%
P/E RatioN/AN/A-
Revenue014.1M-
Total Cash119K29.2M0%
Total Debt1.67M13.7M12%
FUNDAMENTALS RATINGS
QLGN vs VERU: Fundamental Ratings
QLGN
VERU
OUTLOOK RATING
1..100
9756
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
99
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
9894
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QLGN's Valuation (28) in the null industry is significantly better than the same rating for VERU (99) in the Household Or Personal Care industry. This means that QLGN’s stock grew significantly faster than VERU’s over the last 12 months.

QLGN's Profit vs Risk Rating (100) in the null industry is in the same range as VERU (100) in the Household Or Personal Care industry. This means that QLGN’s stock grew similarly to VERU’s over the last 12 months.

VERU's SMR Rating (97) in the Household Or Personal Care industry is in the same range as QLGN (100) in the null industry. This means that VERU’s stock grew similarly to QLGN’s over the last 12 months.

VERU's Price Growth Rating (94) in the Household Or Personal Care industry is in the same range as QLGN (98) in the null industry. This means that VERU’s stock grew similarly to QLGN’s over the last 12 months.

VERU's P/E Growth Rating (100) in the Household Or Personal Care industry is in the same range as QLGN (100) in the null industry. This means that VERU’s stock grew similarly to QLGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
QLGNVERU
RSI
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
87%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
QLGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VERU
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SCMWY58.290.20
+0.35%
Swisscom AG
COKE1210.70-4.51
-0.37%
Coca-Cola Consolidated
AVNW13.79-0.12
-0.86%
Aviat Networks
SAH63.95-0.80
-1.24%
Sonic Automotive
GNLX2.36-0.58
-19.73%
Genelux Corp

QLGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, QLGN has been loosely correlated with HSTO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if QLGN jumps, then HSTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QLGN
1D Price
Change %
QLGN100%
-11.33%
HSTO - QLGN
41%
Loosely correlated
N/A
VERU - QLGN
34%
Loosely correlated
-7.20%
PHIO - QLGN
32%
Poorly correlated
-0.90%
MRNS - QLGN
29%
Poorly correlated
-2.24%
ZLDAF - QLGN
29%
Poorly correlated
N/A
More

VERU and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERU has been loosely correlated with PXXLF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if VERU jumps, then PXXLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERU
1D Price
Change %
VERU100%
-7.20%
PXXLF - VERU
37%
Loosely correlated
N/A
ELVN - VERU
36%
Loosely correlated
-2.05%
PRAX - VERU
35%
Loosely correlated
-6.66%
QLGN - VERU
34%
Loosely correlated
-11.33%
COGT - VERU
33%
Poorly correlated
-7.77%
More